🇰🇷 Lutathera in South Korea

MFDS authorised Lutathera on 26 January 2018

Marketing authorisation

MFDS — authorised 26 January 2018

  • Marketing authorisation holder: AAA USA INC
  • Status: likely_approved

Lutathera in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Lutathera approved in South Korea?

Yes. MFDS authorised it on 26 January 2018.

Who is the marketing authorisation holder for Lutathera in South Korea?

AAA USA INC holds the South Korean marketing authorisation.